Flavohemoglobin requires microaerophilic conditions for nitrosative protection of Staphylococcus aureus

FEBS Letters
Vera L GonçalvesLígia M Saraiva

Abstract

Flavohemoglobins and flavodiiron proteins are two families of enzymes involved in nitrosative detoxification. However, the physiological oxygen-related conditions under which they work and their relative role are still a matter of debate. To address this question we analyzed the function of the putative flavohemoprotein of Staphylococcus aureus, an organism that lacks a flavodiiron-like gene. In this report we show that the recombinant protein contains all features typical of canonical flavohemoglobins and that the transcription of flavohemoglobin gene was upregulated by nitrosative stress in an oxygen-dependent manner. However, and in contrast to other bacterial flavohemoglobins, the S. aureus protein has no apparent role in aerobic nitrosative protection, being only beneficial when cells of S. aureus are submitted to nitrosative stress in a microaerophilic environment. The in vivo data corroborates the proposal that Hmp acts physiologically as a denitrosylase.

References

Feb 15, 1987·Analytical Biochemistry·E A Berry, B L Trumpower
Oct 1, 1985·Analytical Biochemistry·P K SmithD C Klenk
Jan 1, 1994·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·H de LencastreA Tomasz
Oct 1, 1996·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·M Aires de SousaH de Lencastre
Aug 26, 1998·The New England Journal of Medicine·F D Lowy
Sep 2, 1998·Proceedings of the National Academy of Sciences of the United States of America·P R GardnerA L Salzman
Nov 25, 1998·Proceedings of the National Academy of Sciences of the United States of America·A HausladenJ S Stamler
Apr 12, 2000·Proceedings of the National Academy of Sciences of the United States of America·L LiuJ S Stamler
Aug 23, 2001·Proceedings of the National Academy of Sciences of the United States of America·A HausladenJ S Stamler
May 3, 2003·The Journal of Clinical Investigation·Franklin D Lowy
Nov 3, 2004·Advances in Microbial Physiology·Lígia M SaraivaMiguel Teixeira
Nov 18, 2004·The Journal of Biological Chemistry·Marta C JustinoLígia M Saraiva

❮ Previous
Next ❯

Citations

Feb 8, 2013·Applied Microbiology and Biotechnology·Lígia S Nobre, Lígia M Saraiva
Jan 15, 2011·BioTechniques·Michael T ForresterJeremy N Rich
May 3, 2014·Applied Biochemistry and Biotechnology·Aymen EzzineLaura Baciou
Jul 17, 2012·Free Radical Biology & Medicine·Alfred Hausladen, Jonathan S Stamler
Feb 20, 2007·Biochemical and Biophysical Research Communications·Kohei KakishimaYoshihiro Fukumori
Apr 2, 2008·IUBMB Life·Alessandra Bonamore, Alberto Boffi
Jul 25, 2006·Molecular Microbiology·Anthony R RichardsonFerric C Fang
Jan 1, 2012·Scientifica·Paul R Gardner
Feb 22, 2012·Free Radical Biology & Medicine·Michael T Forrester, Matthew W Foster
Sep 8, 2010·Fungal Genetics and Biology : FG & B·Shengmin ZhouHirofumi Shoun
Apr 2, 2013·Biochimica Et Biophysica Acta·Serge N VinogradovDavid Hoogewijs
Apr 25, 2008·Methods in Enzymology·João B VicenteMiguel Teixeira
Nov 9, 2017·Frontiers in Immunology·Eileen Uribe-Querol, Carlos Rosales
Aug 13, 2013·Journal of Bacteriology·Andrew M SternJun Zhu
May 18, 2016·Journal of Bacteriology·Melinda R GrosserAnthony R Richardson
Jan 10, 2019·Microbiology·Kyle D BuchanStephen A Renshaw
Feb 21, 2019·Journal of Bacteriology·Lacey J FavazzoSteven R Gill
May 29, 2020·Antioxidants & Redox Signaling·Viktoria Rungelrath, Frank R DeLeo
Jul 27, 2017·Frontiers in Microbiology·Sandra M CarvalhoLígia M Saraiva
Jun 30, 2016·Pathogens and Disease·William N Beavers, Eric P Skaar
Aug 18, 2020·Science Translational Medicine·Shanna L AshleyRobert P Dickson
Feb 6, 2021·Biological Chemistry·Nico LinznerHaike Antelmann
Oct 20, 2021·FEMS Microbiology Letters·Sandra M CarvalhoLígia M Saraiva

❮ Previous
Next ❯

Related Concepts

Related Feeds

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Related Papers

Methods in Enzymology
Lígia S NobreLígia M Saraiva
Proceedings of the National Academy of Sciences of the United States of America
Alfred HausladenJonathan S Stamler
© 2021 Meta ULC. All rights reserved